Signaling Pathways - Flk1 - MER - constitutive androstane receptor (CAR) - HBV Proteases - Reverse Transcriptases
清除全部
-
B8016 UNC20251 CitationTarget: MER|FLT3Summary: 口服生物可利用的双重MER/FLT3抑制剂 -
B7468 CITCO1 CitationTarget: constitutive androstane receptor (CAR)Summary: 组成型雄激素受体（CAR）激动剂 -
B3709 Midostaurin (PKC412)中文名: 米哚妥林Target: PKC|PKA|KDR|Flk1|PPK|c-Syk|CDK1/CyclinBSummary: PKC抑制剂 -
B2224 Etravirine (TMC125)中文名: 依曲韦林Target: Reverse TranscriptasesSummary: 逆转录酶抑制剂 -
B2223 Zalcitabine中文名: 扎西他滨Target: Reverse TranscriptasesSummary: 逆转录酶抑制剂 -
A8554 Dapivirine (TMC120)中文名: 达匹维林Target: Reverse TranscriptasesSummary: 非核苷逆转录酶抑制剂 -
A8422 Emtricitabine1 Citation中文名: 恩曲他滨Target: Reverse TranscriptasesSummary: 逆转录酶抑制剂 -
A8410 Didanosine中文名: 去羟肌苷Target: Reverse TranscriptasesSummary: 逆转录酶抑制剂 -
A8458 Lamivudine中文名: 拉米夫定，拉美呋定，拉米呋啶Target: HBV ProteasesSummary: 核苷类似物逆转录酶抑制剂 -
A2597 Brivanib (BMS-540215)中文名: 布立尼布Target: VEGFR|FGFR|Flk1Summary: VEGFR-2的ATP竞争性抑制剂